Newbridge Financial Services Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-70
| Closed | -$1.46K | – | 1121 |
|
|
2023
Q3 | $1.46K | Hold |
70
| – | – | ﹤0.01% | 1119 |
|
|
2023
Q2 | $1.68K | Hold |
70
| – | – | ﹤0.01% | 1157 |
|
|
2023
Q1 | $1.32K | Hold |
70
| – | – | ﹤0.01% | 1251 |
|
|
2022
Q4 | $1.11K | Hold |
70
| – | – | ﹤0.01% | 1289 |
|
|
2022
Q3 | $1K | Hold |
70
| – | – | ﹤0.01% | 1263 |
|
|
2022
Q2 | $1K | Hold |
70
| – | – | ﹤0.01% | 1242 |
|
|
2022
Q1 | $2K | Hold |
70
| – | – | ﹤0.01% | 1260 |
|
|
2021
Q4 | $2K | Sell |
70
-150
| -68% | -$4.29K | ﹤0.01% | 1208 |
|
|
2021
Q3 | $4K | Sell |
220
-150
| -41% | -$2.73K | ﹤0.01% | 1037 |
|
|
2021
Q2 | $9K | Hold |
370
| – | – | 0.01% | 999 |
|
|
2021
Q1 | $10K | Buy |
370
+70
| +23% | +$1.89K | 0.01% | 888 |
|
|
2020
Q4 | $16K | Hold |
300
| – | – | 0.01% | 592 |
|
|
2020
Q3 | $12K | Buy |
+300
| New | +$12K | 0.01% | 620 |
|